Project archive

Cancel
  • Coronavirus research at Fraunhofer ITEM

    Fraunhofer vs. Corona: Medical research on SARS-CoV-2

    3D illustration of a lung with a heart.

    Fraunhofer vs. Corona: as an institute with decades of experience in infection and airway research, drug development, biomedical engineering, and in the field of chemical risk assessment, Fraunhofer ITEM can make an important contribution to scientific progress in the fight against the new coronavirus.

    more info
  • Microscopic image of cardiac muscle cells stained green and blue.

    Researchers participating in the RNA Therapeutics platform by the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD are studying circRNAs in human cardiomyocytes from patients that have experienced a SARS-CoV-2 infection.

    more info
  • EU project TBMED

    Open-innovation test bed for high-risk medical devices

    As part of the EU-project TB Med, Fraunhofer ITEM and 12 other project partners are actively participating in the development of a test bed for medical devices of risk classifications IIb and III.

    more info
  • Working with cell cultures.

    To enable better assessment of the safety also of future drugs, Fraunhofer ITEM researchers are developing innovative model systems for assessing immunomodulatory therapeutics.

    more info
  • Nico Lachmann holding a reaction vessel.

    Biomedical researchers are exploring alternative ways of obtaining such immune cells of human origin. Prof. Lachmann and his team have developed a new method laying a foundation for producing them in consistent quality and on large scale.

    more info
  • Fraunhofer ITEM researchers use the ex-vivo model of the isolated perfused rat lung (IPL). In this alternative model, they studied the transition of a fluorescence-labeled substance into the perfusate, which served as blood substitute in this model. Two different methods were used to generate aerosols with different droplet sizes.

    more info